Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;17(6):549-554.
doi: 10.25122/jml-2024-0322.

MiRNAs as potential biomarkers in early breast cancer detection: a systematic review

Ana-Maria Mihai  1 , Laura Maria Ianculescu  1 , Nicolae Suciu  1   2
Affiliations

MiRNAs as potential biomarkers in early breast cancer detection: a systematic review

Ana-Maria Mihai et al. J Med Life. 2024 Jun.

Abstract

Breast cancer remains a significant global health challenge, with high incidence and mortality rates. While mammography has contributed to declining mortality, its limitations in sensitivity and specificity for early detection, particularly in distinguishing between pure atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC), highlight the need for more precise tools. Even with core needle biopsy (CNB), conclusive diagnoses often require surgical excision. This underscores the urgency for non-invasive biomarkers to improve early detection and differentiation, potentially reducing invasive procedures. Recent research has shifted focus from mRNA to microRNAs (miRNAs) as promising biomarkers for breast cancer screening. These small non-coding RNAs, which exhibit abnormal expression patterns in breast cancer patients' tissue and serum/plasma, play crucial roles in early breast cancer development by modulating proto-oncogenes or tumor suppressor genes at the post-transcriptional level. Notably, miRNAs such as miR-21, miR-155, and miR-200c are key regulators of cell proliferation and apoptosis, with the potential to distinguish between normal tissue and various stages of breast lesions, including ADH, DCIS, and IDC. Additionally, miRNAs in serum and plasma offer a non-invasive method to differentiate breast cancer stages. This review aims to consolidate current knowledge on early breast lesions and explore the potential of miRNAs as biomarkers for early breast cancer detection, which could enhance risk prediction and reduce reliance on invasive diagnostic procedures.

Keywords: biomarkers; breast cancer; early detection; miRNAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Fu SW, Lee W, Coffey C, Lean A, Wu X, Tan X, et al. miRNAs as potential biomarkers in early breast cancer detection following mammography. Cell Biosci. 2016 Jan 26;6:6. doi: 10.1186/s13578-016-0071-0. - DOI - PMC - PubMed
    1. Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol. 2011 Jan;223(2):307–17. doi: 10.1002/path.2808. - DOI - PMC - PubMed
    1. Saal LH, Johansson P, Holm K, Gruvberger-Saal SK, She QB, Maurer M, et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc Natl Acad Sci U S A. 2007 May 1;104(18):7564–9. doi: 10.1073/pnas.0702507104. - DOI - PMC - PubMed
    1. Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61–70. doi: 10.1038/nature11412. - DOI - PMC - PubMed
    1. Esteller M. Epigenetics in cancer. N Engl J Med. 2008 Mar 13;358(11):1148–59. doi: 10.1056/NEJMra072067. - DOI - PubMed

Publication types

LinkOut - more resources